Afatinib beyond progression in patients with non-small-cell lung cancer following chemotherapy, erlotinib/gefitinib and afatinib: phase III randomized LUX-Lung 5 trial
Titel:
Afatinib beyond progression in patients with non-small-cell lung cancer following chemotherapy, erlotinib/gefitinib and afatinib: phase III randomized LUX-Lung 5 trial
Auteur:
Schuler, M. Yang, J.C.-H. Park, K. Kim, J.-H. Bennouna, J. Chen, Y.-M. Chouaid, C. De Marinis, F. Feng, J.-F. Grossi, F. Kim, D.-W. Liu, X. Lu, S. Strausz, J. Vinnyk, Y. Wiewrodt, R. Zhou, C. Wang, B. Chand, V.K. Planchard, D.